Market Place
Sourcing Support
Neuland Lab elevates Saradhi Bolli to Global Head of CDMO BD
20 Apr 2026 //
INDPHARMAPOST
Saharsh Davuluri Takes Over As CEO & MD Of Neuland Laboratories
02 Apr 2026 //
PRESS RELEASE
Q2 FY 26 – Financial Results Newspaper Publication
08 Nov 2025 //
PRESS RELEASE
Mr. Sucheth, VC and Chief Executive Officer of Neuland Lab
04 Nov 2025 //
PRESS RELEASE
Neuland Laboratories Q2FY26
24 Oct 2025 //
PRESS RELEASE
Neuland Manufacturing Unit-I Has Been Awarded the Sword of Honour
22 Oct 2025 //
PRESS RELEASE
Signed SE Intimation Trading Window Closure Q2FY26
25 Sep 2025 //
PRESS RELEASE
Neuland’ Manufacturing Unit I secured a Five-Star Safety Rating
29 Aug 2025 //
PRESS RELEASE
Q1 FY 26 – Financial Results Newspaper Publication
01 Aug 2025 //
PRESS RELEASE
Neuland Labs GHG Emission Reduction Targets Approved by SBTi
31 Jul 2025 //
PRESS RELEASE
Outcome of Board Meeting – 31/07/2025
31 Jul 2025 //
PRESS RELEASE
Building a More Sustainable Supply Chain in Pharma
23 Jun 2025 //
PRESS RELEASE
Neuland Labs Q4 FY25 PAT: Rs. 27.80 Cr
18 May 2025 //
INDPHARMAPOST
Neuland Reaffirms Commitment to United Nations Global Principles
08 Apr 2025 //
PRESS RELEASE
Neuland Labs has been awarded a ‘Silver Medal’
26 Mar 2025 //
PRESS RELEASE
Neuland appoints Parag Deshmukh as SVP Head of Manufacturing
24 Mar 2025 //
INDPHARMAPOST
Q3 FY 25 – Financial Results Newspaper Publication
11 Feb 2025 //
PRESS RELEASE
Neuland Labs board approves Capex of Rs. 342 Cr
23 Jan 2025 //
INDPHARMAPOST
Neuland Labs achieved an outstanding ESG Score of 70/100
13 Jan 2025 //
PRESS RELEASE
Neuland Labs Proudly Announces New Vision and Values Statements
07 Jan 2025 //
PRESS RELEASE
Neuland Labs has been recognised as the ‘Top Value Creator’
29 Nov 2024 //
PRESS RELEASE
Q2 FY 25 Financial Results Newspaper Publication
07 Nov 2024 //
PRESS RELEASE
Outcome of Board Meeting – 06/11/2024
06 Nov 2024 //
PRESS RELEASE
Achieving Drug Development Success: Neuland’s Three-Pillar Strategy
03 Oct 2024 //
PRESS RELEASE
Securing Sustainability in Pharma Supply Chain – Sucheth Davuluri
01 Oct 2024 //
PRESS RELEASE
Defining New Rules – The Evolution of the CDMO Industry – Saharsh
02 Sep 2024 //
PRESS RELEASE
Zero Liquid Discharge: Pharma Industry Commitment To Sustainability
02 Aug 2024 //
PRESS RELEASE
Zero Liquid Discharge: A Pharma Industry Commitment to Environment
02 Aug 2024 //
PRESS RELEASE
Neuland Labs Q1FY25
17 Jul 2024 //
PRESS RELEASE
The Pharma Supply Chain: Reshaping Itself for The New Normal
03 Jul 2024 //
PRESS RELEASE
Pharma Supply Chain: Reshaping Itself for The New Normal
03 Jul 2024 //
PRESS RELEASE
Neuland unveils its dynamic new brand identity reinforcing
10 Jun 2024 //
PRESS RELEASE
Neuland Laboratories Q4 FY24 Earnings Conference Call May 14, 2024
14 May 2024 //
PRESS RELEASE
A Check-in on 2024 Trends in the CDMO Industry
02 May 2024 //
PRESS RELEASE
Neuland Labs zooms 6% on US FDA all clear for Hyderabad facility
25 Mar 2024 //
MONEYCONTROL
Neuland Labs Unit I Plant Passes USFDA Audit With Zero 483 Observations Again
24 Mar 2024 //
PRESS RELEASE
Neuland Laboratories Q3 & 9M FY24 Earnings Conference Call” February 09, 2024
13 Feb 2024 //
LIVE MINT
Board Meeting Outcome Unaudited Q3 FY2023-24 Financial Results
08 Feb 2024 //
PRESS RELEASE
Unaudited Financial Results (Consolidated and Standalone) for Q2 FY 2024
07 Nov 2023 //
PRESS RELEASE
Unaudited Financial Results (Consolidated and Standalone) for Q1 FY 2024
03 Aug 2023 //
PRESS RELEASE
Neuland Lab Consolidated June 2023 Net Sales at Rs 362.99 crore, up 64.12% Y-o-Y
03 Aug 2023 //
MONEY CONTROL
Neuland Labs Share Jumps 44% in 3 Days on Strong Q4 Results
15 May 2023 //
EQUITYPANDIT
Neuland Laboratories appoints Abhijit Majumdar as CFO
24 Nov 2022 //
INDIANPHARMAPOST
Neuland Annual Report FY 2021-22
27 Sep 2022 //
PRESS RELEASE
SE Intimation – Resignation of Chief Financial Officer
13 Sep 2022 //
PRESS RELEASE
100 Years of Learning from Pharmaceutical Impurities
18 Mar 2022 //
PRESS RELEASE
Real-Time Remote GMP Inspections by Key Regulatory Agencies
07 Mar 2022 //
PRESS RELEASE
Exploring Neuland’s Therapeutic Segments: Focus on CNS
14 Jan 2022 //
PRESS RELEASE
Green Chemistry by Design (GCbD): The Earlier, The Better for Pharma APIs
03 Jan 2022 //
PRESS RELEASE
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy`s at new highs
17 Sep 2020 //
BUSINESS STANDARD
Neuland Labs gets 5 observations from USFDA for Unit 1 of Bonthapally plant
21 Jun 2019 //
MONEYCONTROL
Neuland Laboratories acquires Arch Pharma Labs
12 Dec 2017 //
INDIAINFOLINE
Neuland to Invest Rs. 300-cr in Next 4 Years to Double its Revenues
31 Dec 2014 //
PHARMABIZ
